Health & Pharm General

Traditional Therapy Clinics Ltd (ASX:TTC) Appendix 4D and Interim Financial Report

🕔8/31/2016 12:52:55 PM

The Traditional Therapy Clinics Ltd (ASX:TTC) Directors present their report, together with the financial statements, on the consolidated entity consisting of Traditional Therapy Clinics Limited and the entities it controlled at the end of, or during, the half-year ended 30 June 2016.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Appendix 4E and Financial Report

🕔8/30/2016 8:20:29 AM

Anatara Lifesciences Ltd (ASX:ANR) today released its Appendix 4E for the period ending 30th June 2016.

Read Full Article

Blackmores Limited (ASX:BKL) Analysts Briefing

🕔8/24/2016 12:41:40 PM

Blackmores Limited (ASX:BKL) (OTCMKTS:BLMMF) are pleased to provide an Analysts Briefing for the full year financial results, year ending 30 June 2016.

Read Full Article

Blackmores Limited (ASX:BKL) Full Year Results Announcement

🕔8/24/2016 10:04:14 AM

Blackmores (ASX:BKL) (OTCMKTS:BLMMF) has announced its fourteenth consecutive year of sales growth, delivering Group sales of $717 million, up 52% on the prior year and resulting in net profit after tax (NPAT) of $100 million, 115% up on the prior year.

Read Full Article

Regeneus Ltd (ASX:RGS) FY16 Results Presentation

🕔8/24/2016 9:59:03 AM

Regeneus Ltd (ASX:RGS) are pleased to provide a Company Presentation for the Full Year Results for FY16.

Read Full Article

Regeneus Ltd (ASX:RGS) FY16 Results Announcement

🕔8/24/2016 9:48:39 AM

Regeneus Ltd (ASX:RGS today reported its 2016 financial results and business update. During the year, the company made significant progress on the development of its portfolio of cell-based therapies for the treatment of osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases for the human and animal health markets.

Read Full Article

Blackmores Limited (ASX:BKL) Annual Report 2016 to Shareholders

🕔8/24/2016 9:41:40 AM

Blackmores Limited (ASX:BKL) (OTCMKTS:BLMMF) are pleased to provide the Company's Annual Report 2016 to shareholders. Blackmores' operations include product innovation and formulation, sourcing of the highest quality ingredients, quality programs to ensure compliance with standards of good manufacturing practice and the marketing, sales and distribution of products to customers and consumers.

Read Full Article